2 unchanged sentences
Our common stock began trading on the Nasdaq Global Select Market under the symbol “FLDM” on February 10, 2011.
+Added: As of April 2022, in connection with the closing of the Private Placement Issuance and the approval of our Eighth Amended and Restated Certificate of Incorporation, our common stock is listed on the Nasdaq Global Select Market under the symbol “LAB”.
We had 79 stockholders of record as of January 31, 2023;
2 unchanged sentences
Instead, we anticipate that all of our earnings in the foreseeable future will be used for the operation and growth of our business.
−Removed: Stock Performance Graph
−Removed: The following performance graph shall not be deemed “soliciting material” or to be “filed” with the SEC for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any filing of Fluidigm Corporation under the Securities Act or the Exchange Act.
−Removed: The following graph compares, from December 31, 2016 through December 31, 2021, the cumulative total return for our common stock, the Nasdaq Composite Total Return Index, and the Nasdaq US Benchmark Medical Equipment Index, assuming in each case an initial investment of $100 and reinvestment of all dividends.
−Removed: Such returns are based on historical results and are not intended to suggest future performance.
Sales of Unregistered Securities
Issuer Purchases of Equity Securities
−Removed: We did not repurchase any shares of our common stock during the year ended December 31, 2021.
+Added: On November 23, 2022, our Board of Directors authorized a share repurchase program (the 2022 Share Repurchase Program) pursuant to which the Company may repurchase up to $20.0 million of the Company’s common stock through open market or privately negotiated transactions until December 31, 2023.
+Added: The repurchases are contingent upon favorable market and business conditions and are funded by cash on hand.
+Added: The program does not obligate the Company to acquire any specific number of shares.
+Added: The following table provides information with respect to the shares of common stock repurchased by us during the three months ended December 31, 2022:
+Added: Period Total Number of Shares Purchased Average Price Paid Per Share (1) Total Number of Shares Purchased as Part of Publicly Announced Program Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
+Added: October 1 - 31, 2022 $— $—
+Added: November 1 - 30, 2022 $— $—
+Added: December 1 - 31, 2022 422,309 $1.33 422,309 $19.4 million
+Added: --------------
+Added: 1 Average price paid per share includes related expenses.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.